Register entry

Collegium Pharmaceutical, Inc.

Registered sites
0
Drug products
13
Live patents
60
Countries
0
Base
Unknown
Sites

Facilities

0

No registered facilities

This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.

Exclusivity

Patents

60

Unexpired Orange Book patents where this company is the application holder.

ProductActive ingredientExpiry
NUCYNTA ERTAPENTADOL HYDROCHLORIDEApr 2028
NUCYNTA ERTAPENTADOL HYDROCHLORIDESept 2028
NUCYNTA ERTAPENTADOL HYDROCHLORIDEOct 2028
NUCYNTA ERTAPENTADOL HYDROCHLORIDEMar 2029
XTAMPZA EROXYCODONEOct 2028
XTAMPZA EROXYCODONEDec 2030
XTAMPZA EROXYCODONESept 2036
Catalogue

Marketed products

13

Showing 13 of 13.

BrandGeneric nameFormCategory
Nucyntatapentadol hydrochlorideTABLET, FILM COATEDNDA
Nucyntatapentadol hydrochlorideTABLET, FILM COATEDNDA
Nucyntatapentadol hydrochlorideTABLET, FILM COATEDNDA
Nucynta ERtapentadol hydrochlorideTABLET, FILM COATED, EXTENDED RELEASENDA
Nucynta ERtapentadol hydrochlorideTABLET, FILM COATED, EXTENDED RELEASENDA
Nucynta ERtapentadol hydrochlorideTABLET, FILM COATED, EXTENDED RELEASENDA
Nucynta ERtapentadol hydrochlorideTABLET, FILM COATED, EXTENDED RELEASENDA
Nucynta ERtapentadol hydrochlorideTABLET, FILM COATED, EXTENDED RELEASENDA
XTAMPZA EROXYCODONECAPSULE, EXTENDED RELEASENDA
XTAMPZA EROXYCODONECAPSULE, EXTENDED RELEASENDA
XTAMPZA EROXYCODONECAPSULE, EXTENDED RELEASENDA
XTAMPZA EROXYCODONECAPSULE, EXTENDED RELEASENDA
XTAMPZA EROXYCODONECAPSULE, EXTENDED RELEASENDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.